Balance Sheet 9 Meters Biopharma, Inc.

Equities

NMTRQ

US6544052086

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 08:46:42 12/09/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

25/03	North American Morning Briefing : Tech in Focus on -2-	DJ
2023	Bidding Procedure Approved for 9 Meters Biopharma, Inc.	CI

ce421119e4e8a86423c3f0c1838.GrY65r8uYl-LMBTufO1Cxw1LGpeUOyeFfT6JF4o_Sk4.e95st9FiGAvhfHPYTdgpo1ccadPtS0azSmHDZftaICRywWuM0WUGafxKYw

Published financial data: 9 METERS BIOPHARMA, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2018	2019	2020	2021	2022
Selling General & Admin Expenses, Total	1.07Cr	1.06Cr	97.2L	92.63L	1.1Cr
R&D Expenses	74.05L	1.37Cr	1.09Cr	2.2Cr	3.1Cr
Other Operating Expenses, Total	1.81Cr	2.43Cr	2.07Cr	3.13Cr	4.2Cr
Operating Income	-1.81Cr	-2.43Cr	-2.07Cr	-3.13Cr	-4.2Cr
Interest Expense, Total	-61.52L	-18.25L	-40.46L	-47.19T	-26.67L
Interest And Investment Income	2L	2L	18.99T	22.71T	5L
Net Interest Expenses	-59.88L	-16.4L	-40.27L	-24.48T	-21.66L
Other Non Operating Income (Expenses)	50T	-76.98T	-37.49L	7T	4L
EBT, Excl. Unusual Items	-2.4Cr	-2.6Cr	-2.84Cr	-3.13Cr	-4.37Cr
In Process R&D Expenses	-	-	-3.23Cr	-51.04L	-
Other Unusual Items	-2L	-10.49L	-8L	-4L	-20.3T
EBT, Incl. Unusual Items	-2.42Cr	-2.7Cr	-6.15Cr	-3.68Cr	-4.38Cr
Earnings From Continuing Operations	-2.42Cr	-2.7Cr	-6.15Cr	-3.68Cr	-4.38Cr
Net Income to Company	-2.42Cr	-2.7Cr	-6.15Cr	-3.68Cr	-4.38Cr
Net Income - (IS)	-2.42Cr	-2.7Cr	-6.15Cr	-3.68Cr	-4.38Cr
Net Income to Common Incl Extra Items	-2.42Cr	-2.7Cr	-6.15Cr	-3.68Cr	-4.38Cr
Net Income to Common Excl. Extra Items	-2.42Cr	-2.7Cr	-6.15Cr	-3.68Cr	-4.38Cr
Per Share Items
Net EPS - Basic	-19.52	-16.23	-11.64	-3.03	-3.38
Basic EPS - Continuing Operations	-19.52	-16.23	-11.64	-3.03	-3.38
Basic Weighted Average Shares Outstanding	12.38L	16.66L	52.82L	1.22Cr	1.3Cr
Net EPS - Diluted	-19.52	-16.23	-11.64	-3.03	-3.38
Diluted EPS - Continuing Operations	-19.52	-16.23	-11.64	-3.03	-3.38
Diluted Weighted Average Shares Outstanding	12.38L	16.66L	52.82L	1.22Cr	1.3Cr
Normalized Basic EPS	-12.12	-9.75	-3.36	-1.61	-2.11
Normalized Diluted EPS	-12.12	-9.75	-3.36	-1.61	-2.11
Supplemental Items
EBITDA	-1.81Cr	-2.43Cr	-2.06Cr	-3.13Cr	-4.2Cr
EBITA	-1.81Cr	-2.43Cr	-2.07Cr	-3.13Cr	-4.2Cr
EBIT	-1.81Cr	-2.43Cr	-2.07Cr	-3.13Cr	-4.2Cr
EBITDAR	-	-2.42Cr	-2.06Cr	-3.12Cr	-4.19Cr
Normalized Net Income	-1.5Cr	-1.62Cr	-1.78Cr	-1.95Cr	-2.73Cr
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	1.07Cr	1.05Cr	96.55L	91.91L	1.09Cr
Research And Development Expense From Footnotes	75.59L	1.37Cr	4.32Cr	2.71Cr	3.1Cr
Net Rental Expense, Total	-	60T	64.8T	71.52T	71.52T
Imputed Operating Lease Interest Expense	-	2L	12.13L	1L	2L
Imputed Operating Lease Depreciation	-	-1L	-11.48L	-63.91T	-81.88T
Stock-Based Comp., R&D Exp. (Total)	24.45L	9L	18.2L	8L	10L
Stock-Based Comp., G&A Exp. (Total)	13.6L	19.63L	29.03L	16.4L	29.88L
Total Stock-Based Compensation	38.05L	28.71L	47.23L	24.13L	39.38L

Fiscal Period: December	2018	2019	2020	2021	2022
Assets
Cash And Equivalents	57.29L	45.93L	3.79Cr	4.7Cr	1.26Cr
Total Cash And Short Term Investments	57.29L	45.93L	3.79Cr	4.7Cr	1.26Cr
Notes Receivable	-	-	-	-	-
Total Receivables	-	-	-	-	-
Prepaid Expenses	5L	6L	10.01L	29.92L	33.59L
Restricted Cash	-	-	-	-	1.7Cr
Other Current Assets, Total	2L	75T	75T	-	-
Total Current Assets	64.14L	52.23L	3.89Cr	5Cr	3.3Cr
Gross Property Plant And Equipment	61.24T	1L	3L	3L	2L
Accumulated Depreciation	-26.15T	-47.76T	-61.46T	-69.03T	-77.55T
Net Property Plant And Equipment	35.1T	68.25T	2L	2L	1L
Other Long-Term Assets, Total	5.58T	5.58T	5.58T	5.58T	7.28T
Total Assets	64.54L	52.97L	3.92Cr	5.02Cr	3.31Cr
Liabilities
Accounts Payable, Total	36.19L	38.9L	14.88L	24.34L	50.53L
Accrued Expenses, Total	9L	47.48L	52.91L	59.68L	43.8L
Short-term Borrowings	51.97L	31.85L	14.22T	-	-
Current Portion of Long-Term Debt	-	-	-	-	1.96Cr
Current Portion of Leases	-	42.83T	48.63T	54.8T	61.75T
Other Current Liabilities	4L	30.46L	7T	-	15.85L
Total Current Liabilities	1.01Cr	1.49Cr	68.48L	84.57L	3.07Cr
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	-	2L	1L	51.4T
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	1.01Cr	1.49Cr	70.16L	85.7L	3.07Cr
Common Stock, Total	2.61T	3.95T	20.46T	25.82T	1.3T
Additional Paid In Capital	3.99Cr	6.09Cr	16Cr	21Cr	22Cr
Retained Earnings	-4.35Cr	-7.06Cr	-13Cr	-17Cr	-21Cr
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	-36.59L	-96.14L	3.21Cr	4.16Cr	24.01L
Total Equity	-36.59L	-96.14L	3.21Cr	4.16Cr	24.01L
Total Liabilities And Equity	64.54L	52.97L	3.92Cr	5.02Cr	3.31Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	13.4L	20.66L	1.08Cr	1.29Cr	1.43Cr
ECS Total Common Shares Outstanding	13.04L	19.74L	1.02Cr	1.29Cr	1.3Cr
Book Value / Share	-2.81	-4.87	3.14	3.22	0.18
Tangible Book Value	-36.59L	-96.14L	3.21Cr	4.16Cr	24.01L
Tangible Book Value Per Share	-2.81	-4.87	3.14	3.22	0.18
Total Debt	51.97L	32.27L	2L	2L	1.97Cr
Net Debt	-5L	-13.65L	-3.76Cr	-4.68Cr	70.83L
Debt Equivalent Oper. Leases	-	5L	5L	6L	6L
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	33.8T	45.73T	42.65T	55.13T	57.97T
Full Time Employees	8	8	12	21	10

Fiscal Period: December	2018	2019	2020	2021	2022
Net Income	-2.42Cr	-2.7Cr	-6.15Cr	-3.68Cr	-4.38Cr
Depreciation & Amortization - CF	19.56T	21.61T	18.49T	7.57T	8.52T
Depreciation & Amortization, Total	19.56T	21.61T	18.49T	7.57T	8.52T
Amortization of Deferred Charges, Total - (CF)	55.91L	11.67L	37.2L	43.98T	18.32L
(Gain) Loss From Sale Of Asset	-	-	39.2T	-	-
Asset Writedown & Restructuring Costs	-	-	2.88Cr	26.11L	-
Stock-Based Compensation (CF)	38.05L	28.71L	47.23L	24.13L	39.38L
Other Operating Activities, Total	2L	11.26L	40.57L	-7T	83.64T
Change In Accounts Payable	86.41T	1L	-24.65L	10.55L	26.19L
Change in Other Net Operating Assets	-7L	37.7L	32.41L	11.78L	-19.57L
Cash from Operations	-1.52Cr	-1.8Cr	-1.94Cr	-2.95Cr	-3.72Cr
Capital Expenditure	-13.94T	-11.93T	-2.54T	-12.48T	-2.84T
Sale (Purchase) of Intangible assets	-	-	-31.84L	-24.93L	-
Other Investing Activities, Total	0	-	-	75T	-
Cash from Investing	-13.94T	-11.93T	-31.87L	-24.31L	-2.84T
Short Term Debt Issued, Total	30L	50L	25L	-	-
Long-Term Debt Issued, Total	3L	-	-	-	2.1Cr
Total Debt Issued	33.45L	50L	25L	-	2.1Cr
Short Term Debt Repaid, Total	-	-77.91L	-24.61L	-58.2T	-
Long-Term Debt Repaid, Total	-3L	-	-	-	-
Total Debt Repaid	-3L	-77.91L	-24.61L	-58.2T	-
Issuance of Common Stock	1.92Cr	2.07Cr	3.97Cr	4.4Cr	-
Issuance of Preferred Stock	-	-	2.26Cr	-	-
Other Financing Activities, Total	-17.57L	-11.02L	-64.21L	-29.01L	-10.88L
Cash from Financing	2.06Cr	1.68Cr	5.59Cr	4.11Cr	1.99Cr
Net Change in Cash	53.73L	-11.36L	3.33Cr	91.42L	-1.73Cr
Supplemental Items
Cash Interest Paid	3L	9L	62.91T	569	8L
Levered Free Cash Flow	-55.07L	-54.48L	-1.55Cr	-1.99Cr	-3.69Cr
Unlevered Free Cash Flow	-72.54L	-53.75L	-1.67Cr	-1.99Cr	-3.71Cr
Change In Net Working Capital	-2L	-68.21L	53.43L	3L	1.48Cr
Net Debt Issued / Repaid	30.7L	-27.91L	38.53T	-58.2T	2.1Cr

Fiscal Period: December	2018	2019	2020	2021	2022
Profitability
Return on Assets	-311.44	-258.31	-58.07	-43.74	-63.03
Return on Total Capital	1.09T	625.98	-99.35	-52.7	-82.19
Return On Equity %	305.2	407.57	-545.95	-99.75	-198.92
Return on Common Equity	305.2	407.57	-545.95	-99.75	-198.92
Short Term Liquidity
Current Ratio	0.63	0.35	5.68	5.91	1.08
Quick Ratio	0.57	0.31	5.53	5.56	0.41
Operating Cash Flow to Current Liabilities	-1.5	-1.21	-2.83	-3.49	-1.21
Long Term Solvency
Total Debt/Equity	-142.02	-33.57	0.72	0.4	821.87
Total Debt / Total Capital	337.97	-50.54	0.71	0.4	89.15
LT Debt/Equity	-	-	0.52	0.27	2.14
Long-Term Debt / Total Capital	-	-	0.52	0.27	0.23
Total Liabilities / Total Assets	156.69	281.51	17.92	17.08	92.76
EBIT / Interest Expense	-2.94	-13.3	-5.1	-662.42	-15.75
EBITDA / Interest Expense	-2.93	-13.26	-5.08	-660.74	-15.72
(EBITDA - Capex) / Interest Expense	-2.94	-13.27	-5.08	-661.01	-15.72
Total Debt / EBITDA	-0.29	-0.13	-0.01	-0.01	-0.47
Net Debt / EBITDA	0.03	0.06	1.83	1.5	-0.17
Total Debt / (EBITDA - Capex)	-0.29	-0.13	-0.01	-0.01	-0.47
Net Debt / (EBITDA - Capex)	0.03	0.06	1.83	1.5	-0.17
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	61.69	33.27	-13.88	51.45	34.42
EBITA, 1 Yr. Growth %	61.78	33.25	-13.88	51.35	34.42
EBIT, 1 Yr. Growth %	61.78	33.25	-13.88	51.35	34.42
Earnings From Cont. Operations, 1 Yr. Growth %	108.19	11.95	127.35	-40.19	19
Net Income, 1 Yr. Growth %	108.19	11.95	127.35	-40.19	19
Normalized Net Income, 1 Yr. Growth %	106.86	7.6	10.62	10.01	39.87
Diluted EPS Before Extra, 1 Yr. Growth %	-0.05	-16.83	-28.27	-74.01	11.65
Net Property, Plant and Equip., 1 Yr. Growth %	-13.79	94.48	231.06	-19.14	-32.84
Total Assets, 1 Yr. Growth %	708.3	-17.93	639.28	28.13	-33.93
Tangible Book Value, 1 Yr. Growth %	-69.95	162.75	-434.33	29.44	-94.23
Common Equity, 1 Yr. Growth %	-69.95	162.75	-434.33	29.44	-94.23
Cash From Operations, 1 Yr. Growth %	197.64	18.45	8.02	51.87	26.34
Capital Expenditures, 1 Yr. Growth %	-64	-14.41	-78.69	390.6	-77.22
Levered Free Cash Flow, 1 Yr. Growth %	797.52	-2.78	194.76	28.38	85.45
Unlevered Free Cash Flow, 1 Yr. Growth %	1.81T	-26.88	221.89	19.31	86.14
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	82.57	47.42	6.47	14.2	42.68
EBITA, 2 Yr. CAGR %	82.65	47.45	6.46	14.16	42.63
EBIT, 2 Yr. CAGR %	82.65	47.45	6.46	14.16	42.63
Earnings From Cont. Operations, 2 Yr. CAGR %	107.35	52.66	59.54	16.61	-15.64
Net Income, 2 Yr. CAGR %	107.35	52.66	59.54	16.61	-15.64
Normalized Net Income, 2 Yr. CAGR %	106.69	49.67	8.47	10.32	24.05
Diluted EPS Before Extra, 2 Yr. CAGR %	134.03	-8.82	-22.76	-56.82	-46.13
Net Property, Plant and Equip., 2 Yr. CAGR %	112.57	29.49	153.74	63.62	-26.31
Total Assets, 2 Yr. CAGR %	276.36	157.56	146.32	207.77	-7.99
Tangible Book Value, 2 Yr. CAGR %	-25.47	-11.14	196.38	108.02	-72.67
Common Equity, 2 Yr. CAGR %	-25.47	-11.14	196.38	108.02	-72.67
Cash From Operations, 2 Yr. CAGR %	164.22	87.76	13.12	28.09	38.52
Capital Expenditures, 2 Yr. CAGR %	27.53	-44.49	-57.29	2.25	5.72
Levered Free Cash Flow, 2 Yr. CAGR %	-	197.96	66.35	94.53	54.3
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	275.85	50.72	95.97	49.02
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	64.85	22.72	19.74	20.58
EBITA, 3 Yr. CAGR %	-	64.89	22.74	19.7	20.55
EBIT, 3 Yr. CAGR %	-	64.89	22.74	19.7	20.55
Earnings From Cont. Operations, 3 Yr. CAGR %	-	68.84	74.34	15.03	17.4
Net Income, 3 Yr. CAGR %	-	68.84	74.34	15.03	17.4
Normalized Net Income, 3 Yr. CAGR %	-	66.63	34.8	8.98	19.4
Diluted EPS Before Extra, 3 Yr. CAGR %	-	65.77	-15.83	-46.28	-40.74
Net Property, Plant and Equip., 3 Yr. CAGR %	-	106.36	77.06	73.32	21.6
Total Assets, 3 Yr. CAGR %	-	126.53	266.03	98.1	84.28
Tangible Book Value, 3 Yr. CAGR %	-	13.43	38.21	124.86	-37.03
Common Equity, 3 Yr. CAGR %	-	13.43	38.21	124.86	-37.03
Cash From Operations, 3 Yr. CAGR %	-	102.22	56.16	24.79	27.5
Capital Expenditures, 3 Yr. CAGR %	-	11.66	-59.66	-3.64	-38.02
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	193.45	52.58	91.45
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	252.73	39.43	92.64
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	41.99	30.35
EBITA, 5 Yr. CAGR %	-	-	-	41.99	30.34
EBIT, 5 Yr. CAGR %	-	-	-	41.99	30.34
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	45.6	30.4
Net Income, 5 Yr. CAGR %	-	-	-	45.6	30.4
Normalized Net Income, 5 Yr. CAGR %	-	-	-	40.96	30.39
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-3.22	-29.59
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	88.06	24.69
Total Assets, 5 Yr. CAGR %	-	-	-	156.07	110.69
Tangible Book Value, 5 Yr. CAGR %	-	-	-	44.57	-27.73
Common Equity, 5 Yr. CAGR %	-	-	-	44.57	-27.73
Cash From Operations, 5 Yr. CAGR %	-	-	-	68.46	48.85
Capital Expenditures, 5 Yr. CAGR %	-	-	-	7.79	-40.69
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	126.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	149.9